Kestra Medical Technologies, Ltd. Financing Receivable, Allowance for Credit Loss
Kestra Medical Technologies, Ltd. (KMTS) had Financing Receivable, Allowance for Credit Loss of -$4.97 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Assets
us-gaap:FinancingReceivableAllowanceForCreditLosses · last filed 2026-09-14
- 2026-07-31: Financing Receivable, Allowance for Credit Loss -$4.97M.
- 2026-04-30: Financing Receivable, Allowance for Credit Loss -$5.79M.
- 2026-01-31: Financing Receivable, Allowance for Credit Loss -$4.71M.
- 2025-10-31: Financing Receivable, Allowance for Credit Loss -$4.34M.
| Period end | Financing Receivable, Allowance for Credit Loss |
|---|---|
| 2026-07-31 | -$4.97M 10-Q · filed 2026-09-14 |
| 2026-04-30 | -$5.79M 10-Q · filed 2026-09-14 |
| 2026-01-31 | -$4.71M 10-Q · filed 2026-03-17 |
| 2025-10-31 | -$4.34M 10-Q · filed 2025-12-11 |
| 2025-07-31 | -$3.81M 10-Q · filed 2025-09-12 |
| 2025-04-30 | -$3.19M 10-K · filed 2026-07-14 |
| 2024-04-30 | -$500.00K 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |